Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/GALMED-PHARMACEUTICALS-LT-16000956/news/Galmed-Pharmaceuticals-Ltd-gibt-den-Beginn-eines-klinischen-Entwicklungsprogramms-zur-Untersuchung-43830630/?utm_source=whatsapp&utm_medium=social&utm_campaign=share